Headlines

Pacific Biosciences Stock Plummets 32% In 21 Sessions: What’s Driving The Decline?

(VIANEWS) – Pacific Biosciences of California (NASDAQ: PACB) shares have fallen by 32.87% over 21 sessions, from EUR10.16 on December 19th to EUR6.82 at 12:41 EST on Monday morning despite two consecutive gains on Thursday and Friday; even as the NASDAQ index increased 0.33% to EUR15,360.97 during that same time frame – Pacific Biosciences’ last…

Read More

FibroGen Soars As Positive Trial Results Boost Optimism

(VIANEWS) – About FibroGen Yearly Analysis Technical Analysis Quarter Analysis Sales Growth desfasoarante FibroGen’s sales growth has been staggering with an impressive 5.3% rise during this quarter and even greater 16.4% expansion scheduled for next. Growth Estimates QuartersAccording to current estimates, the company is projected to experience quarterly growth estimates of 37.1% and 46.9% in…

Read More

Gyrodyne Stock Bullish Momentum With A 10.52% Rise Before The Weekend

(VIANEWS) – The NASDAQ ended the session with Gyrodyne (GYRO) rising 10.52% to $9.98 on Friday while NASDAQ rose 1.7% to $15,310.97. Gyrodyne’s last close was $9.98, 21.17% below its 52-week high of $12.66. About Gyrodyne Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in…

Read More

Less Than One Hour Before The Market Open, NeuroMetrix Is Down By 6%

(VIANEWS) – The NASDAQ opens in less than one hour and NeuroMetrix‘s pre-market value is already 6.65% down. NeuroMetrix’s last close was $3.16, 81.88% under its 52-week high of $17.44. The last session, NASDAQ finished with NeuroMetrix (NURO) jumping 3.61% to $3.16. NASDAQ rose 1.35% to $15,055.65, following the last session’s upward trend on what…

Read More